Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

References on esophageal cancer

  1. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med spiserørskreft.  [Online] September 2008 [hentet 27.oktober2008]; tilgjengelig fra: URL: http://www.shdir.no/vp/multimedia/archive/00021/Nasjonalt_handlingsp_21459a.pdf
  2. Lin CC, Papadopoulos KP. Novel targeted therapies for advanced esophageal cancer. Dis Esophagus 2007; 20(5):365-71.
  3. Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345(10):725-30.
  4. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8(6):545-53.
  5. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77(8):845-57.
  6. Pech O, May A, Rabenstein T, Ell C. Endoscopic resection of early oesophageal cancer. Gut 2007; 56(11):1625-34.
  7. Raja SG, Salhiyyah K, Nagarajan K. Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer? Interact Cardiovasc Thorac Surg 2007; 6(5):661-4.
  8. Rankin SC. Oesophageal cancer: assessment of response and follow up. Cancer Imaging 2007; 7 Spec No A:S67-9.:S67-S69.
  9. Pennathur A, Luketich JD. Resection for esophageal cancer: strategies for optimal management. Ann Thorac Surg 2008; 85(2):S751-S756.
  10. DeMeester SR. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy. Ann Thorac Surg 2008; 85(2):S747-S750.
  11. Schuchert MJ, Luketich JD. Management of Barrett's esophagus. Oncology (Williston Park) 2007; 21(11):1382-9, 1392.
  12. Law S, Wong J. The current management of esophageal cancer. Adv Surg 2007; 41:93-119.:93-119.
  13. Rankin SC. Oesophageal cancer: assessment of response and follow up. Cancer Imaging 2007; 7 Spec No A:S67-9.:S67-S69.
  14. Nathwani RA, Kowalski T. Endoscopic stenting of esophageal cancer: the clinical impact. Curr Opin Gastroenterol 2007; 23(5):535-8.
  15. Lin CC, Papadopoulos KP. Novel targeted therapies for advanced esophageal cancer. Dis Esophagus 2007; 20(5):365-71.
  16. Raja SG, Salhiyyah K, Nagarajan K. Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer? Interact Cardiovasc Thorac Surg 2007; 6(5):661-4.
  17. Gardner-Thorpe J, Hardwick RH, Dwerryhouse SJ. Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 2007; 94(9):1059-66.
  18. Upponi S, Ganeshan A, Slater A et al. Imaging following surgery for oesophageal cancer. Clin Radiol 2007; 62(8):724-31.
  19. Liao Z, Cox JD, Komaki R. Radiochemotherapy of esophageal cancer. J Thorac Oncol 2007; 2(6):553-68.
  20. Siersema PD. Pathogenesis, diagnosis and therapeutic possibilities of esophageal cancer. Curr Opin Gastroenterol 2007; 23(4):456-61.
  21. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8(6):545-53.
  22. Kato H, Fukuchi M, Miyazaki T et al. Surgical treatment for esophageal cancer. Current issues. Dig Surg 2007; 24(2):88-95.
  23. Cancer in Norway 2013, Cancer Registry of Norway, Institute of Population-based Research. Oslo, Norway

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2016